Journal
OPEN BIOLOGY
Volume 13, Issue 9, Pages -Publisher
ROYAL SOC
DOI: 10.1098/rsob.230171
Keywords
plum; myoglianin; Drosophila melanogaster; neuromuscular junction; synapse
Categories
Ask authors/readers for more resources
Alterations in the neuromuscular system contribute to various diseases and aging-related muscle loss. This study identifies Plum as a modulator of MYO function in the neuromuscular system and reveals its role in regulating muscle size and synaptic function.
Alterations in the neuromuscular system underlie several neuromuscular diseases and play critical roles in the development of sarcopenia, the age-related loss of muscle mass and function. Mammalian Myostatin (MST) and GDF11, members of the TGF-beta superfamily of growth factors, are powerful regulators of muscle size in both model organisms and humans. Myoglianin (MYO), the Drosophila homologue of MST and GDF11, is a strong inhibitor of synaptic function and structure at the neuromuscular junction in flies. Here, we identified Plum, a transmembrane cell surface protein, as a modulator of MYO function in the larval neuromuscular system. Reduction of Plum in the larval body-wall muscles abolishes the previously demonstrated positive effect of attenuated MYO signalling on both muscle size and neuromuscular junction structure and function. In addition, downregulation of Plum on its own results in decreased synaptic strength and body weight, classifying Plum as a (novel) regulator of neuromuscular function and body (muscle) size. These findings offer new insights into possible regulatory mechanisms behind ageing- and disease-related neuromuscular dysfunctions in humans and identify potential targets for therapeutic interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available